KMKonstantin V. Melkozerov

Konstantin V. Melkozerov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Konstantin V. Melkozerov has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Electrolyte imbalances as predictors of atrial fibrillation recurrence following radiofrequency catheter ablation in patients with type 2 diabetes mellitus

    by Anastasia S. Myasnikova, Irina Z. Bondarenko, Olga A. Shatskaya, Igor A. Khamnagadaev, Konstantin V. Melkozerov, Raisa S. Bukatsello, Irina S. Gomova, Victor Iu. Kalashnikov, Marina V. Shestakova, Natalia G. Mokrysheva

    Aim. To evaluate the relationship between electrolyte parameters (including serum potassium, magnesium, sodium, and calcium levels), instrumental data (echocardiography), received therapy, and the frequency of early and late recurrences of atrial fibrillation in patients with type 2 diabetes mellitus after radiofrequency ablation. To determine the prognostic value of electrolyte imbalances and glycemic control as potential modifiable risk factors for the failure of interventional treatment. Materials and methods. A retrospective analysis of medical histories of patients who were hospitalized in the cardiology department of Endocrinology Research Centre from 1st January 2017 to 30th October 2025 was conducted. Results. No statistically significant differences between the groups were found in the levels of potassium, sodium, chlorides, and magnesium. The mean total calcium level in both groups was 2.4 mmol/L (p=0.032), with a larger standard deviation observed in the recurrence group. The use of sodium-glucose cotransporter-2 inhibitors was associated with a higher remission rate (67% vs 23%; p=0.005). Glycated hemoglobin (HbA1c) levels were comparable (6.6 and 7.3% respectively). Conclusion. Routinely measured electrolyte disturbances within the range typical for most patients are not independent predictors of long-term recurrences of atrial fibrillation after radiofrequency catheter ablation. Well-controlled type 2 diabetes mellitus (glycated hemoglobin 7%) and therapy with sodium-glucose cotransporter-2 inhibitors are associated with a reduced recurrence rate. Prospective studies are needed to clarify the role of calcium and dynamic electrolyte monitoring.

  • Amiodarone paradox: Hyperthyroxinemia without thyrotoxicosis – a management strategy analysis based on two clinical cases

    by A.N. Zvyagintseva Zvyagintseva, K.V. Melkozerov Melkozerov, I.Z. Bondarenko Bondarenko, O.A. Shatskaya Shatskaya, I.A. Khamnagadaev Khamnagadaev, V.YU. Kalashnikov Kalashnikov, N.M. Platonova Platonova, N.G. Mokrysheva Mokrysheva

  • Open Access

    Clinical and epidemiological aspects of atrial fibrillation and/or atrial flutter in patients with diabetes mellitus: a cross-sectional retrospective population-based study

    by Anastasia S. Myasnikova, Irina Z. Bondarenko, Olga A. Shatskaya, Igor A. Khamnagadaev, Leonid A. Belousov, Konstantin V. Melkozerov, Irina A. Bulavina, Nikolai I. Tiurin, Raisa S. Bukatsello, Irina S. Gomova, et al.

    BACKGROUND: Diabetes mellitus (DM), atrial fibrillation (AF), and atrial flutter (AFL) are among the most prevalent cardiovascular disorders, with their incidence steadily increasing worldwide. The coexistence of DM with AF or AFL is associated with a more severe disease course and a less favorable prognosis compared with each condition occurring independently. AIM: To analyze current clinical and epidemiological aspects of atrial fibrillation (AF) and atrial flutter (AFL) in patients with diabetes mellitus, including sex- and age-related characteristics, distribution by subtype, and the relationship between diabetes mellitus and outcomes after radiofrequency catheter ablation. METHODS: A retrospective analysis of medical records was performed for patients hospitalized in the cardiology department of the National Medical Research Center for Endocrinology named after Academician I.I. Dedov (Moscow, Russia) between January 1, 2017, and October 30, 2025. RESULTS: Among the analyzed discharge summaries, 218 patients (24.9%) had type 2 diabetes mellitus. Of these patients, 30.7% had paroxysmal AF, 22.5% persistent AF, 15.1% persistent AF combined with AFL, 12.8% persistent AFL, 12.4% paroxysmal AF combined with AFL, and 6.5% paroxysmal AFL. Comparative analysis of patient groups with and without diabetes mellitus did not demonstrate convincing evidence of an effect of impaired carbohydrate metabolism on the outcomes of radiofrequency catheter ablation. CONCLUSION: This study clearly demonstrates the prevalence of diabetes mellitus among patients with AF and AFL and identifies criteria for further investigation of the impact of diabetes mellitus on the outcomes and progression of AF. Further study of this issue is required.

  • Open Access

    Advantages of using T1-mapping in cardiac magnetic resonance imaging in patients with acromegaly

    by Alina A. Almaskhanova, Konstantin V. Melkozerov, Elena G. Przhiyalkovskaya, Natalia V. Tarbaeva, Anastasya Y. Korneluk, Raisa S. Kosharnaia, Victor Y. Kalashnikov, Zhanna E. Belaya, Galina A. Mel'NIchenko, Natalia G. Mokrysheva, et al.

    Aim. To determine the incidence of interstitial myocardial fibrosis (MF) in acromegaly, which leads to the development of cardiac arrhythmias and conduction disorders. Materials and methods. A single-center study was conducted, including 70 patients with acromegaly. All patients underwent standard medical examinations, including hormonal blood tests, electrocardiograms, echocardiography, Holter monitoring electrocardiograms and magnetic resonance imaging (MRI) of the heart with gadolinium contrast, additionally 48 patients underwent T1-mapping, which is an MRI method that allows the detection of diffuse changes by measuring the values of myocardial relaxation time – T1. Results. The study revealed a high incidence of MF – 53 (75.7%) cases (21 women, 32 men). The duration of the disease was found to be critical for myocardial remodeling (p=0.006). Compliance criteria for the T1-mapping technique were determined, with reduced T1-mapping values observed in 85.2% of cases. The ROC analysis (Receiver Operator Characteristic) determined the diagnostic value of post-contrast T1-mapping: AUC (Area Under the Curve)=0.906 (95% confidence interval 0.789–1.000), a sensitivity of 90%, and a specificity of 76.5%, indicating high diagnostic efficiency. According to the Youden index, a cut-off point of 372.5 ms was selected. Conclusion. Myocardial T1-mapping is a novel MRI method that allows to assess the degree of MF without the need for myocardial biopsy. The obtained information is crucial for the diagnosis and prognostic assessment of heart diseases, particularly in cases of hypertrophic cardiomyopathy or infiltrative diseases. The T1-mapping method, which is actively developing, can serve as a marker for early diffuse myocardial fibrosis and help determine the prognosis for patients with acromegalic cardiomyopathy.


  • Open Access

    Severe myocardial hypertrophy and fibrosis in a patient with acromegaly: is the prevention of sudden cardiac death needed?

    by A. A. Almaskhanova, K. V. Melkozerov, E. G. Przhiyalkovskaya, N. V. Tarbaeva, R. S. Kosharnaia, I. S. Gomova, P. A. Alferova, L. Ya. Rozhinskaya, V. Y. Kalashnikov, Zh. E. Belaya, et al.

    The most common causes of death in acromegaly are cardiovascular diseases (about 60%). Heart arrhythmias and conduction disorders lead to sudden cardiac death (SCD). In this article, we described a clinical case about preventing SCD in a patient with acromegaly. We identified in this patient predictors of SCD: severe left ventricular hypertrophy, the signs of myocardial fibrosis, decreased systolic function of the left ventricular myocardium, ventricular rhythm disturbances, and heart failure. Patients with acromegaly have higher risk of heart arrhythmias due to development acromegalic cardiomyopathy with includes: left ventricular hypertrophy, diastolic and systolic dysfunction, myocardial fibrosis and electrical disturbances of the myocardium. The main limitation is the lack of special clinical recommendations for the management of this group of patients. Current recommendations based on a standard algorithm and do not consider specificity of acromegalic cardiomyopathy.

  • Open Access

    Diabetes mellitus type 1 and coronary artery disease with severe systolic heart failure in 25 year-old adult

    by A. A. Voznesenskaya, I. Z. Bondarenko, K. V. Melkozerov, R. S. Kosharnaya, A. S. Zakharov, M. Yu. Movsesyants, M. D. Kuklina, V. Yu. Kalashnikov

    Diabetes mellitus (DM) type 1 accounts for up to 90% of all cases of diabetes among children, adolescents and young adults (10 % are represented by T2DM, MODY, etc.). DM is characterized not only by glucose metabolism disorder, but also by abnormal protein and lipid metabolism, leading to severe macrovascular complications. A clinical case of diabetes type 1, hyperlipidemia, coronary artery disease (CAD) and chronic heart failure (HF) in a 25-year-old adult has been demonstrated. The medical examination revealed lipid metabolism disorders, multivessel coronary artery disease, which required myocardial revascularization, and severe heart failure with a reduced ejection fraction (HFrEF). The clinical case demonstrates that proper cardiovascular examination should be performed in all patients with diabetes and lipid disorders, regardless of age and type of diabetes. The authors also consider the use of sodium-glucose


  • Open Access

    Heart arrhythmias and conduction disorders in patients with acromegaly: the role of cardiac magnetic resonance imaging

    by K. V. Melkozerov, E. G. Przhiyalkovskaya, N. V. Tarbaeva, A. A. Almaskhanova, M. D. Kuklina, P. A. Alferova, I. S. Gomova, L. A. Belousov, Z. E. Belaya, A. V. Vorontsov, et al.

    Cardiovascular complications including arrhythmias and cardiac conduction disorders are one of the main reasons of high mortality rate in acromegaly, while they have not been well explored. Aim.To estimate arrhythmias frequency in acromegaly, identify risk factors leading to the development of arrhythmia and cardiac conduction disorder, to determine the role of cardiac MRI in detecting structural and functional changes. Materials and methods.A single-center prospective cohort study, which included 461 patients (151 men and 310 women) with acromegaly, was conducted. All the patients underwent a standard medical examination, including hormonal blood test, electrocardiogram, echocardiography, electrocardiogram daily monitoring. 18 patients with arrhythmias (11 men and 7 women) had cardiac MRI with gadolinium-based contrast. Results.The results of our research show high frequency of arrhythmias and cardiac conduction disorders in patients with acromegaly 42%. Most frequent kinds of arrhythmias and cardiac conduction disorders were sinus bradycardia 19.1% of the cases and conduction disorders of bundle branch blocks 14.5%. Men were more likely to suffer from arrhythmias and cardiac conduction disorders than women (54.2% and 37.4%, respectively,p=0.0005). Not acromegaly activity but duration of the disease was a main risk factor of arrhythmias and cardiac conduction disorders. Patients with arrhythmias had a long anamnesis of acromegaly (10 and 7 years, respectively, p=0.04). Meanwhile, cardiac conduction disorders were commonly observed in the patients who were treated with somatostatin analogs comparing to the patients who didnt undergo this therapy (50% and 38.6% respectively,p=0.004). We showed that 61% of patients with acromegaly and cardiac conduction disorders who underwent magnetic resonance imaging (MRI) had the signs of myocardial fibrosis. The value of the ejection fraction of the left ventricle according to MRI was higher than with echocardiography (p=0.04). Conclusion.Arrhythmias and cardiac conduction disorders are often observed in patients with acromegaly even with remission of the disease. High risk group need careful diagnostic and monitoring approaches. Cardiac MRI is the gold standard for visualization of structural and morphological changes in the heart. Use of cardiac MRI in acromegalic patients expands our understanding of arrhythmias and cardiac conduction disorders in this disease. There are no specific laboratory markers of diffuse myocardial fibrosis, and the role of myocardial fibrosis in the occurrence of cardiac arrhythmias and conduction disorders needs further studying.


  • Open Access

    Sustained ventricular tachycardia in a patient with a single ventricle of the heart and a pheochromocytoma

    by Konstantin V. Melkozerov, Alexander B. Kuznetsov, Victor Yu. Kalashnikov, Fatima М. Abdulkhabirova, Sergey N. Kuznetsov, Anna M. Gorbacheva, Ivan I. Dedov, Кузнецов Александр Борисович, Кузнецов Сергей Николаевич

    A pheochromocytoma is a rare tumor that develops from adrenomedullary chromaffin cells and produce ones or more catecholamines, including adrenaline, norepinephrine, and dopamine. On rare occasions a pheochromocytoma is hormonally inactive. Cyanotic heart disease is also a relatively rare pathology. One of its least frequently occurring variants is the single ventricle of the heart. Presumably, in patients with cyanotic heart defects, the occurrence of pheochromocytes and paragangliomas will be higher due to the presence of certain germinative and somatic mutations. In cyanotic heart defects, the development of malignant arrythmias is one of the frequent causes of death. A combination of a pheochromocytoma with a single ventricle of the heart is extremely rare: only eight such cases have been described in the literature. This article describes a young patient with a unique case of a single ventricle of the heart, pheochromocytoma and sustained ventricular tachycardia. The cause of the ventricular tachycardia, in all likelihood, was inappropriate medical care in this case, a prescription for verapamil. The surgical excision of the pheochromocytoma and the referral of the patient for cardiac surgery became possible only after correcting the antihypertensive and antiarrhythmic therapy. Verapamil was replaced with a combination of doxazosin and amiodarone, resulting in relatively satisfactory blood pressure readings and sinus rhythm.